-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GDD-3898 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GDD-3898 in Obesity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GDD-3898 in Obesity Drug Details: GDD-3898 is under development for the treatment of...
-
Product Insights
NewEndotracheal Tubes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Endotracheal Tubes Pipeline Market Report Overview Endotracheal tubes are used to maintain an unobstructed passageway especially to deliver oxygen or anesthesia to the lungs during surgery or any airway management procedure. The curved tube is placed through the patient's nose or mouth into the trachea (windpipe). The endotracheal tubes pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein...
-
Analyst Opinions
NewImpact of Inflation on United Kingdom (UK) Insurance, 2023 Update
Impact of Inflation on UK Insurance Market Report Overview In 2023, UK inflation dropped from 10.4% in January to 4.0% in December. Economic growth flatlined in the year, with the economy falling into recession in Q4 after two consecutive quarters of negative GDP growth. The top three financial concerns for UK insurance consumers are paying monthly bills, the overall impact of the cost-of-living crisis, and saving for a comfortable retirement. The ‘Impact of Inflation on United Kingdom (UK) Insurance, 2023...
-
Product Insights
Hearing Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Hearing Disorders - Drugs In Development, 2023’, provides an overview of the Hearing Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hearing Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OTO-413 in Hearing Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OTO-413 in Hearing Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OTO-413 in Hearing Disorders Drug Details: OTO-413 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amphotericin B in Cryptococcal Meningitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amphotericin B in Cryptococcal Meningitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amphotericin B in Cryptococcal Meningitis Drug Details: Amphotericin B (MAT-2203)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amphotericin B in Chronic Mucocutaneous Candidiasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amphotericin B in Chronic Mucocutaneous Candidiasis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Amphotericin B in Chronic Mucocutaneous CandidiasisDrug Details:Amphotericin B (MAT-2203) nanoparticle is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Elenestinib in Systemic Mastocytosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Elenestinib in Systemic Mastocytosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Elenestinib in Systemic Mastocytosis Drug Details: BLU-263 is under development for...
-
Product Insights
Spinal Fusion Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Spinal Fusion Pipeline Market Report Overview Spinal Fusion procedures are mainly performed on the cervical and thoracolumbar regions. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, to relieve pain. Conventional and Minimally Invasive Surgery (MIS) methods are used to perform Spinal Fusion. Conventional methods include all open surgical methods that are used for performing spinal procedures. The Spinal Fusion pipeline market research...